The UK-based developer of graphene-based technologies, HexagonFab, recently raised £1.9 million. The funding is to be used to accelerate its development of novel technologies, such as the HexagonFab bolt, a biopharma monitoring tool that was recently taken out of development and released.
Co-founder of HexagonFab Christoph von Bieberstein
“There is huge potential for this technology globally but we are narrowly focusing on where the real value of the business lies. Regarding the technology, we are currently at ‘prototype’ stage and have already engaged potential customers that are testing our tools in the UK, Germany, Switzerland, and the US” Co-founder of HexagonFab Christoph von Bieberstein.